Nucleic acid binding protein 2 pseudogene

This entry refers to a **pseudogene sequence** associated with high homology to a functional nucleic acid binding protein but is incapable of producing a functional protein product. Pseudogenes, including this one, generally arise due to gene duplication or retrotransposition, followed by disabling mutations that prevent protein production. While some pseudogenes have been implicated in regulatory non-coding RNA production or can affect the expression of parental genes through RNA interference mechanisms, most—including this pseudogene—are not considered to have direct biological functions or roles as drug targets[1][2][4][7]. Notes: - This entry ("ENSG00000250815: nucleic acid binding protein 2 pseudogene") does not encode a receptor, enzyme, transporter, or any protein product; instead, it is classified as a nonfunctional genomic sequence, and its inclusion as a therapeutic target is incorrect by accepted biomedical definitions[4][7]. - Pseudogenes are problematic for experimental studies and target annotation because, despite sequence similarity to functional genes, they generally do not yield proteins and do not participate in signaling pathways or drug responses[1][7]. - There is no evidence for clinical significance, biomarker use, therapy, or safety issues related to this pseudogene specifically. If further specificity is required about the likely parent gene for this pseudogene, cross-referencing via genomic databases (such as Ensembl or HGNC) is recommended; however, the core conclusion remains: **this is not a therapeutic or functional molecular target**[4][7].